KemPharm, Inc. Completes Human Abuse Liability Program for KP201/APAP
Positive Results From Second Intranasal Human Abuse Liability Clinical Trial Reaffirm Properties of KP201/APAP Conference Call and Live Audio Webcast Scheduled for Today at 5:00 p.m. ET CORALVILLE, Iowa, Oct. 21, 2015 (GLOBE NEWSWIRE) -- KemPharm, Inc. ( …